6-chloro-9-fluorobenz[g]isoquinoline-5,10-dione | 188622-47-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 6-chloro-9-fluorobenz[g]isoquinoline-5,10-dione
• 英文别名: 6-chloro-9-fluorobenzo[g]isoquinoline-5,10-dione
• CAS: 188622-47-1
• 化学式: C₁₃H₅ClFNO₂
• 分子量: 261.64
• InChiKey: KAQNQVAZWJUHSN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  47
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-chloro-9-fluorobenz[g]isoquinoline-5,10-dione 在 吡啶 、 四丁基氟化铵 、 三乙胺 作用下， 生成 6-[[14-[2-(Dimethylamino)ethyl]-8-oxo-4,14,15-triazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-10-yl]amino]hex-3-ynyl methanesulfonate
  参考文献：
  名称：

  Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh]isoquinolinone derivatives

  摘要：

  A series of indazolo[4,3-gh]isoquinolinones derivatives have been synthesized to decrease cardiotoxic side effects in comparison to Mitoxantrone. The antiproliferative effects of different side chains were investigated and tested on at least four different cell lines of cervix, ovarian, CNS, NSCLC (non-small-cell lung cancer) and colon carcinoma. In addition to antiproliferative activities, influence on cell cycle and intercalation behavior have been tested. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.01.022
• 作为产物：
  描述：

  3-[(5-Chloro-2-fluorophenyl)methyl]pyridine-4-carboxylic acid 在 硫酸 、 三氧化硫 作用下， 反应 0.67h， 以55%的产率得到6-chloro-9-fluorobenz[g]isoquinoline-5,10-dione
  参考文献：
  名称：

  区域异构体6,9-（氯氟）-取代的苯并[ g ]喹啉-5,10-二酮，苯并[ g ]异喹啉-5,10-二酮和6-氯-9-氟-苯并[ g ]喹喔啉-5的合成10二酮

  摘要：

  在四氢呋喃中用锌粉处理二氟或氯氟取代的苄基溴化物5a-c，得到相应的苄基溴化锌6a-c。这些通过镍催化介导的用氯取代的杂环酯4A和4B处理的有机金属进行偶联，得到二卤代苄基取代的杂环酯7Aa-c和7Ba-c。在钯催化下用6c处理4c可得到7cc。通过将这些酯水解制得的酸8（经发烟硫酸处理）进行环化和氧化反应，得到所需的区域异构体二卤代杂环醌2。

  DOI：

  10.1002/jhet.5570340105

文献信息

• N-tert-butoxycarbonyl-N-substituted hydrazines in SNAr displacements. Synthetic pathways to N-1-substituted anthrapyrazoles, aza-anthrapyrazoles and aza-benzothiopyranoindazoles
  作者：Ambrogio Oliva、Michael Ellis、L. Fiocchi、Ernesto Menta、A. Paul Krapcho

  DOI：10.1002/jhet.5570370108

  日期：2000.1

  stituted hydrazines has been accomplished. The use of these protected hydrazines in SNAr substitutions leads to products in which the most nucleophilic nitrogen displaces the leaving group. Treatment of these compounds with trifluoroacetic acid readily removes the Boc-protecting group and the intermediates readily undergo cyclizations to yield N-1-substituted aza-benzothiopyranoindazoles, anthrapyrazoles

  的几个合成ñ -叔-protected-丁氧羰基（BOC）ñ -取代的肼已经完成。在S N Ar取代中使用这些受保护的肼会生成大多数亲核氮取代离去基团的产物。用三氟乙酸处理这些化合物容易除去Boc保护基，并且中间体容易进行环化以产生N -1-取代的氮杂-苯并硫代吡喃并吲哚，蒽并吡咯和氮杂-蒽并吡咯。在一些氮杂-蒽吡唑的合成中采用了侧链积累。
• Paul Krapcho, Journal of Medicinal Chemistry, 1998, vol. 41, # 27, p. 5429 - 5444
  作者：Paul Krapcho

  DOI：——

  日期：——
• Hypoxia Activated Prodrugs of a 9-Aza-anthrapyrazole Derivative That Has Promising Anticancer Activity
  作者：Mohammad H. El-Dakdouki、Nicholas Adamski、Lecia Foster、Miles P. Hacker、Paul W. Erhardt

  DOI：10.1021/jm200984x

  日期：2011.12.8

  Mono- and his-N-oxides of a 9-aza-anthrapyrazole derivative having two 2-(dimethylamino)ethyl appendages were prepared by using a mild oxaziridine reagent. Biochemical and cell culture assays indicate that the bis-oxide is an inactive prodrug that readily converts to the active parent molecule under hypoxic conditions that are analogous to those present within certain tumors.
• Synthesis and Antitumor Evaluation of Bis Aza-anthracene-9,10-diones and Bis Aza-anthrapyrazole-6-ones
  作者：Ippolito Antonini、Giorgio Santoni、Roberta Lucciarini、Consuelo Amantini、Diego Dal Ben、Rosaria Volpini、Gloria Cristalli

  DOI：10.1021/jm7013937

  日期：2008.2.1

  The good results obtained as potential antitumor drugs with aza-anthracenediones and aza-anthrapyrazoles, e.g. pixantrone, 1a, and 1b (Chart 1), prompted us to design and synthesize a series of symmetrical bis derivatives, compounds 7-10 (Chart 1). These compounds are dimers of different aza-anthracenedione and aza-anthrapyrazolone monomers connected by the linker found to be the most appropriate among potential bis intercalators synthesized by us. The DNA-binding properties of bis derivatives 7 and 8 have been examined using fluorometric techniques: these target compounds are excellent DNA ligands, with a clear binding site preference for AT-rich duplexes. In vitro cytotoxic activity of all target compounds 7-10 and of reference compound pixantrone toward human cancer adenocarcinoma cell line HT29 is also described. Two selected compounds have been investigated for their capacity of inducing early apoptosis.